Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent

Synapse

Volumn 40, Issue 4, 2001, Pages 282-293

  Zhu, Hongbo ^a   Barr, Gordon A ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Age dependent; MK 801; Morphine dependence; Preweaning; Withdrawal

Indexed keywords

DIZOCILPINE; MORPHINE; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

AGE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; KNOCKOUT GENE; MORPHINE ADDICTION; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY;

AGE FACTORS; ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MORPHINE; MORPHINE DEPENDENCE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0035877350     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1051     Document Type: Article

References (57)

1. Age-related functional changes of the glutamate receptor channels in rat Meynert neurones
2. NMDA EPSCs at glutamatergic synapses in the spinal cord dorsal horn of the postnatal rat
3. Behavioral effects of opiates during development
4. Reinforcing properties of opiates during early development
5. Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat
6. Developmental changes in glutamate receptor-activated translocation of protein kinase C in cerebellar granule neurons
7. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat
8. Changes in voltage dependence of NMDA currents during development
9. Developmental increase in the sensitivity to magnesium of NMDA receptors on CA1 hippocampal pyramidal cells
10. Postnatal development of glutamate receptor-mediated responses in the neostriatum
11. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A
12. Plasticity of NMDA receptor expression during mouse cerebellar granule cell development
13. The glutamate receptor ion channels
14. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway
15. Developmental biology of inflammatory pain
16. The postnatal development of spinal sensory processing
17. Development of excitatory amino acid induced cytotoxicity in cultured neurons
18. Development of excitatory amino acid dependent 45Ca2+ uptake in cultured cerebral cortex neurons
19. Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist
20. Opioid tolerance and dependence: A new model highlighting the role of metabotropic glutamate receptors
21. Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists
22. A simple technique for the permanent marking of newborn albino rats
23. NMDA receptor subunit gene expression in the rat brain: A quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A
24. Hippocampal NMDA receptor mRNA undergoes subunit specific changes during developmental lead exposure
25. Developmental alterations in NMDA receptor-mediated [Ca2+]i elevation in substantia gelatinosa neurons of neonatal rat spinal cord
26. Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence
27. Quantitative and qualitative changes in AMPA receptor expression during spinal cord development
28. In situ hybridization analysis of AMPA receptor subunit gene expression in the developing rat spinal cord
29. Ontogeny of morphine withdrawal in the rat
30. Opiate withdrawal in the fetal rat: A behavioral profile
31. Synchronized overproduction of AMPA, kainate, and NMDA glutamate receptors during human spinal cord development
32. N-methyl-D-aspartate receptors are transiently expressed in the developing spinal cord ventral horn
33. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids
34. Potential anti-anxiety, anti-addictive effects of LY354740, a selective group II glutamate metabotropic receptors agonist in animal models
35. NMDA and opioid receptors: Their interactions in antinociception, tolerance and neuroplasticity
36. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions
37. Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons
38. Opioid systems and the newborn
39. Mechanisms of opioid tolerance: A current view of cellular mechanisms
40. [3H]MK-801 binding sites in neonate rat brain
41. Reduced sensitivity of the N-methyl-D-aspartate component of synaptic transmission to magnesium in hippocampal slices from immature rats
42. Glutamate receptors in the mammalian central nervous system
43. Transient increase of NMDA-binding sites in human hippocampus during development
44. Treatment with excitatory amino acids or high K+ and NMDA receptors in cerebellar granule cells
45. Developmental maturation of the N-methyl-D-aspartic acid receptor channel complex in postnatal rat brain
46. Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice
47. Characterization of neonatal rat fentanyl tolerance and dependence
48. Characterization of neonatal rat morphine tolerance and dependence
49. Ontogeny of mu opioid agonist anti-nociception in postnatal rats
50. Transient increased density of NMDA binding sites in the developing rat hippocampus
51. Cellular and molecular mechanisms of opioid tolerance and dependence: Progress and pitfalls
52. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
53. Opiate tolerance and dependence: Recent findings and synthesis
54. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal
55. The ontogeny of mu opiate tolerance and dependence in the rat: Antinociceptive and biochemical studies
56. Subunit- and site-specific pharmacology of the NMDA receptor channel
57. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists